Intelligo

Private limited company · Asker

MED KJEMI AS

ActiveWholesale of pharmaceutical and medical goods (46.460)

Founded
1 Jan 1987
Employees
5
Chief executive
Karin Stangeland
Business address
Drengsrudbekken 9, 1383 Asker

The life line 1997–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 52.4m.

  1. Chair took office§ 07
  2. Managing director took office§ 07

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

MED KJEMI AS is a private limited company in Asker, founded in 1987, in the industry wholesale of pharmaceutical and medical goods. The chief executive is Karin Stangeland, and the chair of the board is Jan Knoph. In 2025 the company had NOK 52.4m in operating revenue and a net profit of NOK 7.1m. The largest owner is MARMED AS with 46.0%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 30 Sep 2026

  • Endring av styre
  • Annual accounts filed 2024 → 2025
  • Godkjent årsregnskap
  • Won a tender from SYKEHUSINNKJØP HF

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

1 point

  • Note2 of 2 on the board are new in the last 12 months

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 52.4m in 2025

Revenue

NOK 52.4m

−4.6% from 2024

20232025

Operating profit

NOK 9.1m

+206.5% from 2024

20232025

Net profit

NOK 7.1m

+223.3% from 2024

20232025

Equity

NOK 6.8m

+19.5% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 15%
  • Depreciation 0%
  • Other operating costs 10%
  • Not specified in the source 57%
  • Left as operating result 17%

Of the net profit for 2025, NOK 1.1m stayed in the company. The rest, NOK 6.0m, is an assumed dividend.

The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 34.9%

RevenueNOK 52.4m Operating margin17.4% Equity ratio34.9% Revenue growth−4.6%
  • MED KJEMI AS, 2025
  • Industry median, assumed: NOK 8.5m · 4.3% · 41.6% · +7.3%

Equity NOK 6.8m35% of the assets (NOK 19.5m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 538 companies in 46.460 Wholesale of pharmaceutical and medical goods, not stated by the source.

Finances

§ 06 Accounts

28 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue52,40454,91052,551
Operating profit9,0962,9681,084
Profit before tax9,1192,833988
Net profit7,1072,198768
Total assets19,49215,27116,696
Equity6,7945,6874,489
Liabilities12,6999,58412,207

Source: the Register of Company Accounts, read 15 Nov 2026 · All 28 years →

Management and ownership

§ 07 Officers

4 officers now

The board: 2 members

Source: the Brønnøysund Register Centre, read 1 Oct 2026 · All 4 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Daglig leder og ett styremedlem i fellesskap.

May sign for the company:

Daglig leder og ett styremedlem i fellesskap.

Procuration: none registered.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 23 Aug 2026

Management and ownership

§ 09 Owners

2 shareholders · largest 46.0%

OwnerShare
MARMED AS
46.0%
MED-HOLD AS
46.0%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 2 owners →

Management and ownership

§ 10 Group

1 subsidiary

MED KJEMI AS parent company

The group 2023: operating revenue NOK 52.4m.

Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

13 connections

  • Person
  • Company

2 people link MED KJEMI AS to 7 other companies: Jan Knoph 7 and Robert Andrzej Kolakowski 4.

Source: the Brønnøysund Register Centre, read 1 Oct 2026 · Explore the network →

Events and registers

§ 13 Events

38 since 2015

Events per year

20152026

  • Notices73
  • Tenders won5
  • Register changes1

Since 2015: 73 announcements, 1 register change and 5 tenders won. Most happened in 2023 and 2024.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 38 events →

Events and registers

§ 14 Notices

73, latest 30 Sep 2026

  • Styre
  • Godkjente årsregnskap
  • Styre

Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 73 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 19 Feb 1995
  • VATRegistered
  • The Register of Business EnterprisesRegistered 29 Oct 1988
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Produksjons-, handels- og agenturvirksomhet av spesialprodukter og farmasøytiske preparater overfor norske leger, sykehus, helsetjeneste, forskningslaboratorier og apotek, og alt som hermed står i forbindelse, herunder deltagelse med eierandeler i andre selskaper.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

5 tenders

  • 2023
  • 2023
  • 2024
  • 2024
  • 2024
  • Won
  • Lost

Source: Doffin and TED, read 5 Nov 2026. · All 5 tenders →

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 46.460

Value awarded in Doffin and TED since 2023, among the companies MED KJEMI AS has met in tenders:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

7 questions

  • Who is the chief executive of MED KJEMI AS?
    Karin Stangeland, since 2024. § 07
  • Who owns MED KJEMI AS?
    2 shareholders. The largest is MARMED AS with 46.0% and MED-HOLD AS with 46.0%. § 09
  • What was the revenue in 2025?
    NOK 52.4m in the company. § 06
  • Who can sign for MED KJEMI AS?
    Daglig leder og ett styremedlem i fellesskap. § 08
  • Who is the auditor?
    BDO AS, from 2 Feb 2012. § 07
  • Where is MED KJEMI AS based?
    Drengsrudbekken 9, 1383 Asker.
  • When was MED KJEMI AS founded?
    1 Jan 1987, registered in the Register of Business Enterprises 29 Oct 1988. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose